ClinicalThought

Share

Program Content

Activities

  • OC: 1st-Line Maintenance Niraparib
    My Perspective on the Recent Approval of Niraparib as First-line Maintenance Therapy in Ovarian Cancer and the Clinical Implications
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 11, 2021

    Expires: January 10, 2022

Provided by

ProCE Banner

Supporters

GlaxoSmithKline